Table 2. Basic burden tests associating disruptive variants in SETD1A to schizophrenia and developmental disorders.
Phenotype | Data set | Case | Control | Test | P value |
---|---|---|---|---|---|
Schizophrenia | All schizophrenia case-control samples (ignoring de novo status) | 10 of 7,776 | 0 of 13,028 | ||
Non-schizophrenia ExAC exomes | 2 of 45,376 | ||||
All samples | 10 of 7,776 | 2 of 58,404 | Fisher’s exact | 2.6 × 10−8 | |
Neurodevelopmental disorders | DDD study | 4 of 4,281 | See notea | Fisher’s exact | 2.9 × 10−4 |
ASD trios | 0 of 2,297 | ||||
ID trios | 0 of 151 | ||||
Combined | All samples | 14 of 14,505 | 2 of 58,404 | Fisher’s exact | 1.2 × 10−8 |
De novo status of variants was ignored was non-schizopherenia exomes from the ExAC database were incorporated as controls. The number of SETD1A LoF variants and the sample size of each data set were indicated in each cell.
The full control data set (n = 58,404) was used to calculated the P value.